Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.2%

2 terminated/withdrawn out of 48 trials

Success Rate

94.9%

+8.4% vs industry average

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

73%

27 of 37 completed trials have results

Key Signals

5 recruiting27 with results

Enrollment Performance

Analytics

N/A
38(88.4%)
Phase 1
2(4.7%)
Phase 4
1(2.3%)
Early Phase 1
1(2.3%)
Phase 3
1(2.3%)
43Total
N/A(38)
Phase 1(2)
Phase 4(1)
Early Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (48)

Showing 20 of 48 trials
NCT06834568Not ApplicableCompleted

Tandem Freedom - Feasibility Trial 2

Role: lead

NCT07211126Recruiting

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

Role: lead

NCT07517770Not ApplicableNot Yet Recruiting

Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)

Role: collaborator

NCT07039617Not ApplicableRecruiting

A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)

Role: collaborator

NCT07325461Not ApplicableRecruiting

Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

Role: lead

NCT05785832Not ApplicableCompleted

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Role: lead

NCT04614168Not ApplicableCompleted

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

Role: collaborator

NCT04510506Not ApplicableCompleted

Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation

Role: collaborator

NCT07020936Not ApplicableRecruiting

AIDANET Pediatrics

Role: collaborator

NCT06428591Not ApplicableCompleted

Tandem Freedom Feasibility Study 1

Role: lead

NCT06717451Active Not Recruiting

PS230005 Control-IQ 1.5 Post-Approval Study

Role: lead

NCT06273124Not ApplicableCompleted

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

Role: lead

NCT06880835Not ApplicableRecruiting

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

Role: collaborator

NCT06633965Not ApplicableCompleted

Safety and Feasibility Testing of a Smaller Network Version of AIDANET

Role: collaborator

NCT05610111Not ApplicableCompleted

Adaptive Biobehavioral Control (ABC) in a Closed-Loop System

Role: collaborator

NCT05422053Not ApplicableCompleted

Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)

Role: lead

NCT04016662Phase 4Completed

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

Role: collaborator

NCT05683392Not ApplicableCompleted

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

Role: lead

NCT04233034Phase 3Completed

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Role: collaborator

NCT04439903Not ApplicableCompleted

Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus

Role: collaborator